---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-21-005791"
form_type: "8-K"
ticker: "PMDI"
cik: "0000806517"
company_name: "PSYCHEMEDICS CORP"
filed_at: "2021-08-10T23:59:59+00:00"
generated_at: "2026-06-29T17:35:44.299462+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Psychemedics Q2 2021 revenue up 85% to $6.1M, swings to net income of $0.1M

## Summary
- Revenue $6.1M vs $3.3M in Q2 2020 (+85%); net income $0.1M ($0.02 EPS) vs net loss $2.1M (-$0.37).
- Domestic revenue up ~80%, driven by Oil & Gas, Manufacturing, Transportation segments; international revenue up 153% on small base.
- Recorded $0.8M employee retention tax credit (ERC) under CAA; expects eligibility for Q3 and Q4 2021.
- PPP loan of $2.2M fully forgiven by SBA in July 2021; cash $2.7M, working capital $7.1M as of June 30.
- Dividend remained suspended since Q1 2020; board continues to evaluate quarterly.

## SEC filing metadata
- accession: 0001171843-21-005791
- form_type: 8-K
- ticker: PMDI
- cik: 0000806517
- company_name: PSYCHEMEDICS CORP
- filed_at: 2021-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/806517/000117184321005791/0001171843-21-005791-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/806517/000117184321005791/f8k_081021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-21-005791
- JSON: https://secwatch.observer/filing/0001171843-21-005791.json
- Plain text: https://secwatch.observer/filing/0001171843-21-005791.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.